ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

Core Insights - ImmunityBio, Inc. and nCartes, Inc. have entered a collaboration to automate and streamline the data fulfillment process for clinical trials, aiming to enhance efficiency and reduce costs for trial investigators [1][2][3] Group 1: Collaboration Details - The collaboration will utilize digital information from electronic medical record (EMR) systems to directly populate Electronic Data Capture (EDC) systems, replacing the traditional manual data entry process [2][3] - This new approach is expected to reduce delays in clinical trials, improve data quality by minimizing entry errors, and lower costs associated with source data verification [3][4] Group 2: Company Profiles - ImmunityBio is a vertically-integrated biotechnology company focused on developing therapies and vaccines that enhance the immune system to combat cancers and infectious diseases, with a notable product being ANKTIVA®, the first FDA-approved immunotherapy for non-muscle invasive bladder cancer [5] - nCartes is a cloud software platform provider that enables clinical research sponsors to automate data capture for clinical trials and other applications, leveraging electronic health systems [4][5]